Pure Financial Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Pure Financial Advisors's REGN Position: Q2 2026 in Review
Pure Financial Advisors increased its Regeneron Pharmaceuticals (REGN) stake by 7.3% in Q2 2026, buying an estimated $25.9K and bringing the position to 561 shares worth $350K. The position accounts for ﹤0.01% of the portfolio, ranked #458.
Pure Financial Advisors first reported a position in REGN in Q3 2025 and has held it in 4 quarters since. The position peaked at $404K in Q1 2026. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Pure Financial Advisors held 561 shares of Regeneron Pharmaceuticals worth $350K as of Q2 2026.
- Pure Financial Advisors bought 38 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $25.9K.
- Regeneron Pharmaceuticals made up ﹤0.01% of Pure Financial Advisors's portfolio in Q2 2026, its #458 holding.
- Pure Financial Advisors first reported a position in Regeneron Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
- Pure Financial Advisors's Regeneron Pharmaceuticals position peaked at $404K in Q1 2026.
- 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Pure Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.